News
Media
Multimedia Series
Conferences
Partners
CME/CE
Resources
Advisory Board
Subscribe

Spotlight -

This Year In Medicine 2025

Nancy Reau, MD

Nancy Reau, MD | Image Credit: Rush University

Nancy Reau, MD, is Professor of Internal Medicine, Richard B. Capps Chair of Hepatology, Associate Director of Solid Organ Transplantation, and Section Chief of Hepatology at Rush University Medical Center.

Articles by Nancy Reau, MD

Unmet Needs in HBV Thumbnail featuring Nancy Reau, MD, Andrew Talal, MD, and Chari Cohen, DrPH, MPH

Role of Advocacy, Patient Voice in Hepatitis B

ByNancy Reau, MD,Andrew Talal, MD,Chari Cohen, DrPH, MPH

May 19th 2024

In this segment of our 6-part discussion on updates and unmet needs within the management of hepatitis B virus focuses on the role of advocacy and patient voice in HBV management.

Unmet Needs in HBV Thumbnail featuring Nancy Reau, MD, Andrew Talal, MD, and Chari Cohen, DrPH, MPH

Discussing Unmet Needs in Hepatitis B for 2024

ByNancy Reau, MD,Andrew Talal, MD,Chari Cohen, DrPH, MPH

May 19th 2024

In this segment of our 6-part discussion on updates and unmet needs within the management of hepatitis B virus focuses on the most pressing unmet needs in HBV for 2024.

Unmet Needs in HBV Thumbnail featuring Nancy Reau, MD, Andrew Talal, MD, and Chari Cohen, DrPH, MPH

Therapeutic Pipeline Updates in Hepatitis B Virus for 2024

ByNancy Reau, MD,Andrew Talal, MD,Chari Cohen, DrPH, MPH

May 19th 2024

In this segment of our 6-part discussion on updates and unmet needs within the management of hepatitis B virus focuses on updates in the therapeutic pipeline.

Unmet Needs in HBV Thumbnail featuring Nancy Reau, MD, Andrew Talal, MD, and Chari Cohen, DrPH, MPH

Improving Hepatitis B Screening and Vaccination in 2024

ByNancy Reau, MD,Andrew Talal, MD,Chari Cohen, DrPH, MPH

May 19th 2024

In this segment of our 6-part discussion on updates and unmet needs within the management of hepatitis B virus focuses on the need to improve HBV screening and vaccination.

Unmet Needs in HBV Thumbnail featuring Nancy Reau, MD, Andrew Talal, MD, and Chari Cohen, DrPH, MPH

Implications of HBV DNA Integration on Care in 2024

ByNancy Reau, MD,Andrew Talal, MD,Chari Cohen, DrPH, MPH

May 19th 2024

In this segment of our 6-part discussion on updates and unmet needs within the management of hepatitis B virus focuses on how advancing understanding of HBV DNA integration is influencing care in 2024.

Unmet Needs in HBV Thumbnail featuring Nancy Reau, MD, Andrew Talal, MD, and Chari Cohen, DrPH, MPH

Advances in Pathophysiology of Hepatitis B Virus for 2024

ByNancy Reau, MD,Andrew Talal, MD,Chari Cohen, DrPH, MPH

May 19th 2024

In this segment of our 6-part discussion on updates and unmet needs within the management of hepatitis B virus focuses on advances in the pathophysiology of hepatitis b virus for 2024.

The Future and Resources in HCV Care

ByAnthony Martinez, MD,Tipu V. Khan, MD,Jordan Mayberry, MPAS, PA-C,Nancy Reau, MD,Mark Sulkowski, MD

December 21st 2023

Expert hepatologists discuss future developments in HCV that they are excited about and provide resources for new providers to get started on delivering HCV care.

Challenges in HCV Care

ByAnthony Martinez, MD,Tipu V. Khan, MD,Jordan Mayberry, MPAS, PA-C,Nancy Reau, MD,Mark Sulkowski, MD

December 21st 2023

The panelists discuss challenges faced in HCV care, especially in addiction medicine and strategies to overcome them.

Practical Implementation of HCV Care

ByAnthony Martinez, MD,Tipu V. Khan, MD,Jordan Mayberry, MPAS, PA-C,Nancy Reau, MD,Mark Sulkowski, MD

December 14th 2023

The panelists offer practical tips on implementing HCV care into your clinical practice.

Monitoring Treatment and Confirming the Cure of HCV

ByAnthony Martinez, MD,Tipu V. Khan, MD,Jordan Mayberry, MPAS, PA-C,Nancy Reau, MD,Mark Sulkowski, MD

December 7th 2023

Experts in HCV care discuss monitoring HCV treatment.

Adherence and HCV Treatment

ByAnthony Martinez, MD,Tipu V. Khan, MD,Jordan Mayberry, MPAS, PA-C,Nancy Reau, MD,Mark Sulkowski, MD

December 7th 2023

The panelists discuss adherence in HCV treatment.

Treatment Options for HCV

ByAnthony Martinez, MD,Tipu V. Khan, MD,Jordan Mayberry, MPAS, PA-C,Nancy Reau, MD,Mark Sulkowski, MD

November 30th 2023

An overview of treatment regimens for HCV.

Candidates for HCV Treatment

ByAnthony Martinez, MD,Tipu V. Khan, MD,Jordan Mayberry, MPAS, PA-C,Nancy Reau, MD,Mark Sulkowski, MD

November 30th 2023

Expert hepatologist Mark Sulkowski, MD discusses which patients are candidates for HCV treatment.

Baseline Lab Test to initiate HCV treatment

ByAnthony Martinez, MD,Tipu V. Khan, MD,Nancy Reau, MD,Jordan Mayberry, MPAS, PA-C,Mark Sulkowski, MD

November 27th 2023

An overview of the baseline laboratory blood tests recommended before initiating HCV treatment.

Screening for Hepatitis C

ByAnthony Martinez, MD,Tipu V. Khan, MD,Jordan Mayberry, MPAS, PA-C,Nancy Reau, MD,Mark Sulkowski, MD

November 27th 2023

Experts in Hepatitis care discuss simplified screening practices for HCV.

Task shifting in HCV care

ByAnthony Martinez, MD,Tipu V. Khan, MD,Jordan Mayberry, MPAS, PA-C,Nancy Reau, MD,Mark Sulkowski, MD

November 16th 2023

The panelists discuss the importance of the role of task shifting in Hepatitis C care.

The Hepatitis C Elimination Goal

ByAnthony Martinez, MD,Tipu V. Khan, MD,Jordan Mayberry, MPAS, PA-C,Nancy Reau, MD,Mark Sulkowski, MD

November 16th 2023

Experts discuss where we currently stand on the World Health Organization elimination goals for Hepatitis C virus.

Trending on HCPLive

OMA 2026 Recap: Pediatrics, Retention, and Lifestyle Changes in Obesity

OMA 2026 Recap: GLP-1s in Conditions Beyond Obesity

A Real-World Case: Initiating Ritlecitinib After Years of Untreated Disease

Choosing Among Approved JAK Inhibitors: Baricitinib, Ritlecitinib, and Deuruxolitinib

Red Flags for Misdiagnosed Type 2, When to Order Antibodies and C‑Peptide